{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:14:12Z","timestamp":1773465252558,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jchf.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T17:35:39Z","timestamp":1556559339000},"page":"371-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Aaron M.","family":"Hein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Edmonston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"DeVore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib2","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3: Suppl","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2019.02.009_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000368915","article-title":"Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study","volume":"40","author":"Rahman","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jchf.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCHEARTFAILURE.113.000553","article-title":"Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure","volume":"6","author":"Bosselmann","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.02.009_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2009.12.016","article-title":"Influence of renal function on the use of guideline-recommended therapies for patients with heart failure","volume":"105","author":"Heywood","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.10611015","article-title":"Antihypertensive medication use in older patients transitioning from chronic kidney disease to end-stage renal disease on dialysis","volume":"11","author":"Chang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2019.02.009_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"de Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ejhf.778","article-title":"The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction","volume":"19","author":"Nayor","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.109.853648","article-title":"Proteinuria, chronic kidney\u00a0disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure","volume":"120","author":"Anand","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.kint.2017.04.019","article-title":"Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) controversies conference","volume":"92","author":"Baigent","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2019.02.009_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ahj.2018.07.019","article-title":"Worsening renal function during decongestion among patients hospitalized for heart failure: findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial","volume":"204","author":"Fudim","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.02.009_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cardfail.2011.08.009","article-title":"Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure","volume":"17","author":"Testani","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib18","first-page":"41","article-title":"The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease","volume":"24","author":"Dounaevskaia","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jchf.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease","volume":"153","author":"Berger","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2011.12.056","article-title":"Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD treatment trial","volume":"167","author":"Bowling","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cardfail.2006.05.008","article-title":"Effects of angiotensin-converting enzyme inhibitors in systolic heart failure patients with chronic kidney disease: a propensity score analysis","volume":"12","author":"Ahmed","year":"2006","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9149(90)90475-G","article-title":"Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS trial study group","volume":"66: Suppl D","author":"Swedberg","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehv268","article-title":"Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study","volume":"36","author":"Edner","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.02.009_bib27","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jchf.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: A Bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2019.02.009_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2016.03.024","article-title":"Long-term changes of renal function in relation to ace inhibitor\/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease","volume":"178","author":"Frohlich","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.02.009_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib31","first-page":"489","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.02.009_bib32","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/ejhf.603","article-title":"Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis","volume":"18","author":"Solomon","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib33","first-page":"e282","volume":"134","author":"Yancy","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2019.02.009_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40256-015-0130-7","article-title":"Potential new agents for the management of hyperkalemia","volume":"16","author":"Packham","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jchf.2019.02.009_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib38","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2013.04.086","article-title":"Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and\/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)","volume":"62","author":"Eschalier","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib41","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11255-016-1319-7","article-title":"Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis","volume":"48","author":"Lu","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jchf.2019.02.009_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2014.03.062","article-title":"Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction\u00a0<45%, and estimated glomerular filtration rate\u00a0<45 ml\/min\/1.73 m(2)","volume":"114","author":"Inampudi","year":"2014","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jchf.2019.02.009_bib43","article-title":"Use of mineralocorticoid receptor antagonists in patients with heart failure and comorbid diabetes mellitus or chronic kidney disease","volume":"6","author":"Cooper","year":"2017","journal-title":"J\u00a0Am Heart Assoc 2017"},{"key":"10.1016\/j.jchf.2019.02.009_bib44","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ehf2.12265","article-title":"Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease","volume":"5","author":"Pitt","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2019.02.009_bib48","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2019.02.009_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/eurjhf\/hfq038","article-title":"Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial","volume":"12","author":"Castagno","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib51","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Badve","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1253\/circj.CJ-17-0442","article-title":"Anemia is associated with blunted response to beta-blocker therapy using carvedilol\u2014insights from Japanese Chronic Heart Failure (J-CHF) study","volume":"82","author":"Nagatomo","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2019.02.009_bib53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardfail.2013.01.006","article-title":"Effectiveness of beta-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease","volume":"19","author":"Chang","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.02.009_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2019.02.009_bib56","first-page":"623","article-title":"Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials","volume":"2","author":"Steinberg","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.02.009_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cardfail.2008.03.009","article-title":"Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate","volume":"14","author":"Boerrigter","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2019.02.009_bib58","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2011.05.024","article-title":"Device therapy in heart failure patients with chronic kidney disease","volume":"58","author":"Cannizzaro","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919301520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919301520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:51:05Z","timestamp":1761972665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177919301520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213177919301520"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2019.02.009","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}